• NuWays maintained Buy on OHB with an unchanged EUR 340 price target in its Nov. 13, 2026, report.
• The firm cut 2026 estimates for softer growth and higher one-off costs, lowering 2027 forecasts for a slower program ramp-up.
• Third-quarter adjusted EBITDA rose 12% to EUR 39.3 million, lifting the margin to 12.3%.
• SATCOMBw 4 remains the largest potential catalyst, with NuWays anticipating EUR 5 billion–7 billion in orders in the first half of 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OHB SE published the original content used to generate this news brief via EQS News (Ref. ID: rc_27484) on November 13, 2026, and is solely responsible for the information contained therein.